Compare GRFS & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | TKR |
|---|---|---|
| Founded | 1940 | 1899 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.5B |
| IPO Year | N/A | 1994 |
| Metric | GRFS | TKR |
|---|---|---|
| Price | $8.48 | $108.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $10.15 | ★ $110.00 |
| AVG Volume (30 Days) | ★ 649.3K | 590.0K |
| Earning Date | 07-28-2022 | 05-06-2026 |
| Dividend Yield | ★ 1.63% | 1.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.11 |
| Revenue | N/A | ★ $80,100,000.00 |
| Revenue This Year | $4.69 | $4.50 |
| Revenue Next Year | $6.49 | $3.97 |
| P/E Ratio | ★ $18.67 | $26.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.90 | $60.85 |
| 52 Week High | $11.14 | $111.39 |
| Indicator | GRFS | TKR |
|---|---|---|
| Relative Strength Index (RSI) | 53.66 | 61.92 |
| Support Level | $8.27 | $105.18 |
| Resistance Level | $9.08 | $111.19 |
| Average True Range (ATR) | 0.21 | 2.60 |
| MACD | 0.09 | 0.68 |
| Stochastic Oscillator | 67.73 | 91.03 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.